Vanguard Australian Shares Index ETF Has Lifted 20% in a Year. Which Stocks Have Contributed Most to Its Rise?

The Motley FoolDec 1 16:20 ET

Clarity Pharmaceuticals Completes Final Patient Assessment in Phase 2 Neuroendocrine Tumor Trial; Shares Rise 7%

MT NewswiresNov 27 22:42 ET

3 ASX 300 Stocks up by More Than 300% in a Year

The Motley FoolNov 26 17:10 ET

Clarity Pharmaceuticals Doses First Two Participants in Prostate Cancer Imaging Trial

MT NewswiresNov 25 19:44 ET

3 ASX Healthcare Shares Surging on Big News

The Motley FoolNov 25 19:32 ET

Clarity Pharmaceuticals Issues New Equity Options

TipRanksNov 24 22:48 ET